Restricting Access To Medication Abortion Will Not Help Survivors Of Intimate Partner Violence Elizabeth Tobin-Tyler Kari White Maeve Wallace Samuel Dickman February 26, 2026

https://www.healthaffairs.org/content/forefront/restricting-access-medication-abortion-not-help-survivors-intimate-partner-violence Despite its well-established safety profile, mifepristone—one of two medications used for abortion—is under an FDA safety review, at the request of the Trump Administration. Mail order, an evidence-based delivery mechanism for the medication, is also under scrutiny; anti-abortion groups now claim that if mifepristone is available by mail, abusive men will use it to coerce women into having unwanted abortions. Therefore, they argue, it should only be available through an in-person clinic visit, or not at all.